Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia

Oelke, 2013, EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction, Eur Urol, 64, 118, 10.1016/j.eururo.2013.03.004

Roehrborn, 2005, ILC IN THE TREATMENT OF BPH Benign Prostatic Hyperplasia: An Overview, Rev Urol, 7, 3

Gravas, 2018, EAU Guidelines Panel on Treatment of Non-neurogenic Male LUTS Guidelines: Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO), Eur Assoc Urol, 36, 575

Avins, 2010

Somani, 2014, Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH), BJU Int, 114, 639, 10.1111/bju.12672

Bagla, 2014, Early Results from a United States Trial of Prostatic Artery Embolization in the Treatment of Benign Prostatic Hyperplasia, J Vasc Intervent Radiol, 1

Pisco, 2013, 2561

Antunes, 2014, 1602

Stucki, 2015, Bipolar versus monopolar transurethral resection of the prostate: A prospective randomized trial focusing on bleeding complications, J Urol, 193, 1371

Gao, 2014, Benign Prostatic Hyperplasia: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate—A Prospective, Randomized, and Controlled Clinical Trial, Radiology, 270, 920, 10.1148/radiol.13122803

Cakir, 2018, The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia, Prostate Int, 6, 71, 10.1016/j.prnil.2017.12.003

Taneja, 2017, Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population, Prostate Int, 5, 158, 10.1016/j.prnil.2017.04.004

Demirdag, 2016, The Clinical Effect of Bipolar and Monopolar Transurethral Resection of the Prostate More Than 60 Milliliters, Urology, 98, 132, 10.1016/j.urology.2016.08.008

Ray, 2018, Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: An observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study), BJU Int, 270, 10.1111/bju.14249

Shim, 2017, Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression, J Urol, 197, 465

Christidis, 2018, Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy, World J Urol, 36, 575, 10.1007/s00345-018-2220-z

Carnevale, 2016, Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis, Cardiovasc Intervent Radiol, 39, 44, 10.1007/s00270-015-1202-4

Roehrborn, 2008, Medical therapy options for aging men with benign prostatic hyperplasia: Focus on alfuzosin 10 mg once daily, Clin Interv Aging, 3, 511, 10.2147/CIA.S3635